Skip to main content

News

New CDC Guidelines on Prescribing Opiates for Pain

The use of opioids has become increasingly problematic in the last few years. First, the rising rates of use and abuse, followed by greater restrictions and regulations that have curtailed use, and, finally, a resultant increase in illicit drug use (heroin) and opioid overdoses.

Leflunomide and Weight Loss in Rheumatoid Arthritis

Weight change can have substantial effects on the outcomes of patients with arthritis. It has long been known that weight loss and low body mass index (BMI) are associated with poorer arthritis outcomes.

The Week in Review - 11 March 2016

Highlights from this week at RheumNow.com:

Risk Factors for Pulmonary Hypertension in Lupus

Fidler and colleagues from Toronto have recently shown that pulmonary disease is common in lupus, as they found 56% of their patients with abnormal pulmonary assessments.

ACR Invites Comment on Perioperative Management Guidelines

The ACR is inviting members and rheumatologists to comment on their proposal to develop recommendations for the "Perioperative Management of Rheumatic Disease Medications in Total Joint Arthroplasty of the Hip and Knee".   

Combined Dermatology-Rheumatology Clinics Benefits Patients

Healio reports that patients followed in a combined Dermatology and Rheumatology clinic in Canada revealed high patient satisfaction. 

Outpatient Surgery Safe for Total Hip

ORLANDO -- Total hip replacement can be performed safely and effectively on an outpatient basis for healthy patients, a researcher reported here.

Biosimilars Reviewed by Expert Panel

As the number of biosimilars in development keeps on growing, reaching nearly 700 products to date, demand for data from randomized controlled trials (RCTs) and an understanding of these new biologics  is peaking the interest of many. 

Tocilizumab Induces and Maintains Remission in Giant Cell Arteritis

Lancet has reported the results of a randomized, double-blind, placebo-controlled trial of tocilizumab in patients with new-onset giant cell arteritis (GCA).

"Lost to Follow-up" Patients are Common in Rheumatology

The frequency of not returning (lost to follow-up) (LTFU) in patients with rheumatic diseases is high. Associated demographic factors included older age in RA, female gender in SLE and Ps/PsA, and younger age in Ps/PsA, with various reasons for being LTFU.

Drugs that May Induce Raynaud's

A systematic review by Khouri examined the extent drugs are capable of inducing Raynaud's phenomenon (RP).

Ixekizumab Superior to Etanercept in Psoriasis

The UNCOVER-2 and UNCOVER-3 trials were presented at the American Academy of Dermatology (AAD) Annual Meeting taking this week in Washington, D.C.

Vitamin D has No Effect on Knee Osteoarthritis

Vitamin D supplementation for individuals with knee osteoarthritis and low 25-hydroxyvitamin D levels did not reduce knee pain or slow cartilage loss, according to a study appearing in the March 8 issue of JAMA.
 

Novel Protein as a Potential Autoantigen in JIA

Juvenile idiopathic arthritis (JIA) is clearly not related to rheumatoid arthritis and until recently has no identifiabile autoantigen linked to JIA.

Pregnancies are Adversely Affected Even Before the Diagnosis of Lupus

Arkema and colleagues assessed maternal and fetal outcomes in patients with SLE, pre-clinical (prior to onset) SLE and prevalent maternal SLE during pregnancy compared with the general population.

×